Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HilleVax, Inc. - Common Stock (NQ: HLVX )

17.59 -0.18 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,229
Open 18.12
Bid (Size) 7.140 (1)
Ask (Size) 28.12 (2)
Prev. Close 17.77
Today's Range 17.21 - 18.15
52wk Range 7.900 - 24.42
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HilleVax: Q1 Earnings Insights
 
Via Benzinga
HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire

Performance

YTD
+16.49%
+16.49%
1 Month
+24.40%
+24.40%
3 Month
+15.72%
+15.72%
6 Month
+7.91%
+7.91%
1 Year
+90.37%
+90.37%

More News

Read More
HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of Directors
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine Candidate
From HilleVax, Inc.
Via GlobeNewswire
HilleVax's Norovirus Vaccine Shows Long-Term Immunogenicity
Via Benzinga
HilleVax Reports Full Year 2022 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Executive Management Appointments and Promotions
From HilleVax, Inc.
Via GlobeNewswire
HilleVax to Present at the 41st Annual J.P. Morgan Healthcare Conference
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Positive Immunogenicity Results for Run-In Cohort of NEST-IN1 Phase 2b Clinical Trial of HIL-214 Norovirus Vaccine Candidate
From HilleVax, Inc.
Via GlobeNewswire
Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday
Via Benzinga
HilleVax to Participate in November Investor Conferences
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Uber, Lyft, AZZ And Other Big Losers From Tuesday
Via Benzinga
Revlon Climbs, Singing Machine Moves Up And Weber Makes Big Move: 5 Short Squeeze Stocks That May Soar This Week
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Via Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
Via Benzinga
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Via Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Via Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.